Sign In
Buy AMPH
$19.94
-0.440 (-2.16%)
At Close: Jul 31, 2026
Needham Sticks to Its Buy Rating for Revance Therapeutics (RVNC)
10:29am, Wednesday, 15'th Apr 2020
In a report released today,
Serge Belanger
from Needham maintained a
Buy
rating on Revance Therapeutics (
RVNC
–
Research Report
), with a price target of
$36.00
. The company’s shares closed last
Alliancebernstein L.P. Purchases 1,400 Shares of Amphastar Pharmaceuticals Inc (NASDAQ:AMPH)
08:28am, Wednesday, 15'th Apr 2020
Alliancebernstein L.P. boosted its position in Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) by 1.3% during the fourth quarter, Holdings Channel.com reports. The fund owned 109,340 shares of the company
Needham Reaffirms Their Buy Rating on Trevi Therapeutics (TRVI)
04:36pm, Tuesday, 14'th Apr 2020
In a report released today, Serge Belanger from Needham maintained a Buy rating on Trevi Therapeutics (TRVI), with a price target of $18.00. The company's
Needham Reaffirms Their Buy Rating on Trevi Therapeutics (TRVI)
04:36pm, Tuesday, 14'th Apr 2020
In a report released today, Serge Belanger from Needham maintained a Buy rating on Trevi Therapeutics (TRVI – Research Report),
Amphastar Pharma's President bids adieu
11:44am, Tuesday, 14'th Apr 2020
Amphastar Pharmaceuticals (NASDAQ:AMPH) announces that Mr. Jason B. Shandell has stepped down as President, General Counsel, and member of the Board of Directors, effective April 10. Dr. Jack Y. Zha
BRIEF-Amphastar Pharmaceuticals Inc Simplifies Management Structure
10:03pm, Monday, 13'th Apr 2020
Amphastar Pharmaceuticals Inc:
Amphastar Pharmaceuticals, Inc. Announces Simplification of Management Structure
09:20pm, Monday, 13'th Apr 2020Amphastar Pharmaceuticals, Inc. Announces Simplification of Management Structure
09:16pm, Monday, 13'th Apr 2020
Mr. Jason B. Shandell has stepped down as President, General Counsel, and member of the Board of Directors, effective April 10, 2020. Mr. Shandell and the Company have mutually agreed that now is the
Amphastar Pharmaceuticals, Inc. Announces Simplification of Management Structure
09:16pm, Monday, 13'th Apr 2020
RANCHO CUCAMONGA, Calif., April 13, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (“Amphastar” or the “Company”), a...
Needham Remains a Hold on BioCryst (BCRX)
09:55am, Monday, 13'th Apr 2020
In a report released today, Serge Belanger from Needham maintained a Hold rating on BioCryst (BCRX). The company's shares closed last Thursday at $2.07,
Needham Remains a Hold on BioCryst (BCRX)
09:55am, Monday, 13'th Apr 2020
In a report released today, Serge Belanger from Needham maintained a Hold rating on BioCryst (BCRX – Research Report). The
Needham Sticks to Their Buy Rating for Collegium Pharmaceutical (COLL)
09:54am, Monday, 13'th Apr 2020
Needham analyst Serge Belanger maintained a Buy rating on Collegium Pharmaceutical (COLL) today and set a price target of $38.00. The company's shares
Analysts Offer Insights on Healthcare Companies: Aerie Pharma (AERI) and Neurocrine (NBIX)
09:51am, Monday, 13'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Aerie Pharma (AERI) and Neurocrine (NBIX) with bullish
Analysts Offer Insights on Healthcare Companies: Aerie Pharma (NASDAQ: AERI) and Neurocrine (NASDAQ: NBIX)
09:51am, Monday, 13'th Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Aerie Pharma (
AERI
–
Research Report
) and Neurocrine (
NBIX
–
Research Report
) with bullish sent
Stocks To Watch: Big Banks And Vaccine Players In The Spotlight
12:35pm, Saturday, 11'th Apr 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
